arrow left
arrow right
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
						
                                

Preview

FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 759 RECEIVED NYSCEF: 02/01/2023 EXHIBIT 14 Letter from Director of DOH Medical Marijuana Program Denying Fiorello’s Application to Change Ownership, Dated August 23, 2018 FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 759 RECEIVED NYSCEF: 02/01/2023 Index No. 652343/2018 FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 759 RECEIVED NYSCEF: 02/01/2023 August 23, 2018 VIA CERTIFIED AND ELECTRONIC MAIL to eric@fpnys.com Eric Sirota Co-Chief Executive Officer Fiorello Pharmaceuticals 12 East 49th Street, 11th Floor New York, New York 10017 Dear Mr. Sirota: This letter is in response to your email dated July 12, 2018, requesting the review and approval of the New York State Department of Health (Department) for an ownership change of Fiorello Pharmaceuticals (Fiorello) to Green Thumb Industries (GTI). The proposed ownership change would result in GTI, a proposed new investor, owning one hundred percent of Fiorello. The Department issued a registration to Fiorello on August 1, 2017. Pursuant to 10 NYCRR § 1004.8, the registration issued to Fiorello is non-transferrable. The Department has reviewed your request and hereby denies the proposed change in ownership, as it would constitute a direct transfer of the registration. In addition, Fiorello has not demonstrated progress toward beginning operations. Pursuant to 10 NYCRR § 1004.9, a registered organization is required to surrender its registration to the Department upon written notice and demand if the registered organization fails to begin operations, to the satisfaction of the Department, of a manufacturing and/or dispensing facility within six months of the date of issuance of the registration. The Department has provided flexibility with this requirement to help support a phased-in approach of new registered organizations. Nonetheless, based on documentation submitted by Fiorello to the Department, it appears that Fiorello is unable to begin operations to the satisfaction of the Department without the proposed change in ownership with GTI. Please submit an updated timeline demonstrating how Fiorello will begin operations, to the satisfaction of the Department, by the end of the calendar year. Please submit a confirmatory email to mmp@health.ny.gov to acknowledge receipt of this letter. Should you have any questions concerning this letter, please feel free to contact me directly at (518) 402-0705. Sincerely, Nicole K. Quackenbush, Pharm.D. Director Medical Marijuana Program